ISENTRESS (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the ISENTRESS drug offered from Merck Sharp & Dohme Corp.. This HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | RALTEGRAVIR |
SUBSTANCE NAME: | RALTEGRAVIR POTASSIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | GRANULE, FOR SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-12-20 |
END MARKETING DATE: | 0000-00-00 |
ISENTRESS HUMAN PRESCRIPTION DRUG Details:
Item Description | ISENTRESS from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2013-12-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0006-3603_dea5d8a6-af2b-46c0-ba65-3a3f7b2fd1ec |
PRODUCT NDC: | 0006-3603 |
APPLICATION NUMBER: | NDA205786 |
Other RALTEGRAVIR POTASSIUM Pharmaceutical Manufacturers / Labelers: